Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 973560

Critical Considerations on the Clinical Translation of Upconversion Nanoparticles (UCNPs): Recommendations from the European Upconversion Network (COST Action CM1403)


Oliveira, Helena; Bednarkiewicz, Artur; Falk, Andreas; Fröhlich, Eleonore; Lisjak, Darja; Prina-Mello, Adriele; Resch, Susanne; Schimpel, Christa; Vinković Vrček, Ivana; Wysokinska, Edyta; Gorris, Hans H.
Critical Considerations on the Clinical Translation of Upconversion Nanoparticles (UCNPs): Recommendations from the European Upconversion Network (COST Action CM1403) // Advanced Healthcare Materials, 8 (2019), - doi:10.1002/adhm.201801233 (međunarodna recenzija, osvrt, znanstveni)


CROSBI ID: 973560 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Critical Considerations on the Clinical Translation of Upconversion Nanoparticles (UCNPs): Recommendations from the European Upconversion Network (COST Action CM1403)

Autori
Oliveira, Helena ; Bednarkiewicz, Artur ; Falk, Andreas ; Fröhlich, Eleonore ; Lisjak, Darja ; Prina-Mello, Adriele ; Resch, Susanne ; Schimpel, Christa ; Vinković Vrček, Ivana ; Wysokinska, Edyta ; Gorris, Hans H.

Izvornik
Advanced Healthcare Materials (2192-2640) 8 (2019);

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, osvrt, znanstveni

Ključne riječi
Bioimaging ; efficacy, quality and safety (EQS) ; lanthanides ; nanosafety ; research, development and innovation (R&D&I) ; safe-by-design ; theranostics

Sažetak
The unique photoluminescent properties of upconversion nanoparticles (UCNPs) have attracted worldwide research interest and inspired many bioanalytical applications. The anti-Stokes emission with long luminescence lifetimes, narrow and multiple absorption and emission bands, and excellent photostability enable background-free and multiplexed detection in deep tissues. So far, however, in vitro and in vivo applications of UCNPs are restricted to the laboratory use due to safety concerns. Possible harmful effects may originate from the chemical composition but also from the small size of UCNPs. Potential end users must rely on well-founded safety data. Thus, a risk to benefit assessment of the envisioned combined therapeutic and diagnostic (“theranostic”) applications is fundamentally important to bridge the translational gap between laboratory and clinics. The COST Action CM1403 “The European Upconversion Network—From the Design of Photon-Upconverting Nanomaterials to Biomedical Applications” integrates research on UCNPs ranging from fundamental materials synthesis and research, detection instrumentation, biofunctionalization, and bioassay development to toxicity testing. Such an interdisciplinary approach is necessary for a better and safer theranostic use of UCNPs. Here, the status of nanotoxicity research on UCNPs is compared to other nanomaterials, and routes for the translation of UCNPs into clinical applications are delineated.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Interdisciplinarne prirodne znanosti



POVEZANOST RADA


Projekti:
HRZZ-IP-2016-06-2436 - Značaj interakcija metalnih nanočestica sa sumpornim biomolekulama za nano-bio sučelje (NanoFaceS) (Vinković Vrček, Ivana, HRZZ - 2016-06) ( CroRIS)

Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb

Profili:

Avatar Url Ivana Vinković Vrček (autor)

Poveznice na cjeloviti tekst rada:

doi onlinelibrary.wiley.com

Citiraj ovu publikaciju:

Oliveira, Helena; Bednarkiewicz, Artur; Falk, Andreas; Fröhlich, Eleonore; Lisjak, Darja; Prina-Mello, Adriele; Resch, Susanne; Schimpel, Christa; Vinković Vrček, Ivana; Wysokinska, Edyta; Gorris, Hans H.
Critical Considerations on the Clinical Translation of Upconversion Nanoparticles (UCNPs): Recommendations from the European Upconversion Network (COST Action CM1403) // Advanced Healthcare Materials, 8 (2019), - doi:10.1002/adhm.201801233 (međunarodna recenzija, osvrt, znanstveni)
Oliveira, H., Bednarkiewicz, A., Falk, A., Fröhlich, E., Lisjak, D., Prina-Mello, A., Resch, S., Schimpel, C., Vinković Vrček, I., Wysokinska, E. & Gorris, H. (2019) Critical Considerations on the Clinical Translation of Upconversion Nanoparticles (UCNPs): Recommendations from the European Upconversion Network (COST Action CM1403). Advanced Healthcare Materials, 8, - doi:10.1002/adhm.201801233.
@article{article, author = {Oliveira, Helena and Bednarkiewicz, Artur and Falk, Andreas and Fr\"{o}hlich, Eleonore and Lisjak, Darja and Prina-Mello, Adriele and Resch, Susanne and Schimpel, Christa and Vinkovi\'{c} Vr\v{c}ek, Ivana and Wysokinska, Edyta and Gorris, Hans H.}, year = {2019}, pages = {---}, DOI = {10.1002/adhm.201801233}, keywords = {Bioimaging, efficacy, quality and safety (EQS), lanthanides, nanosafety, research, development and innovation (R and D and I), safe-by-design, theranostics}, journal = {Advanced Healthcare Materials}, doi = {10.1002/adhm.201801233}, volume = {8}, issn = {2192-2640}, title = {Critical Considerations on the Clinical Translation of Upconversion Nanoparticles (UCNPs): Recommendations from the European Upconversion Network (COST Action CM1403)}, keyword = {Bioimaging, efficacy, quality and safety (EQS), lanthanides, nanosafety, research, development and innovation (R and D and I), safe-by-design, theranostics} }
@article{article, author = {Oliveira, Helena and Bednarkiewicz, Artur and Falk, Andreas and Fr\"{o}hlich, Eleonore and Lisjak, Darja and Prina-Mello, Adriele and Resch, Susanne and Schimpel, Christa and Vinkovi\'{c} Vr\v{c}ek, Ivana and Wysokinska, Edyta and Gorris, Hans H.}, year = {2019}, pages = {---}, DOI = {10.1002/adhm.201801233}, keywords = {Bioimaging, efficacy, quality and safety (EQS), lanthanides, nanosafety, research, development and innovation (R and D and I), safe-by-design, theranostics}, journal = {Advanced Healthcare Materials}, doi = {10.1002/adhm.201801233}, volume = {8}, issn = {2192-2640}, title = {Critical Considerations on the Clinical Translation of Upconversion Nanoparticles (UCNPs): Recommendations from the European Upconversion Network (COST Action CM1403)}, keyword = {Bioimaging, efficacy, quality and safety (EQS), lanthanides, nanosafety, research, development and innovation (R and D and I), safe-by-design, theranostics} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font